Merging Forces for Better Healthcare
Salt Lake City-based Recursion Pharmaceuticals and UK cancer research specialist Exscientia are set to merge in a significant $688 million deal. This merger aims to enhance drug discovery, making high-quality medicines more affordable and accessible.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
